BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 9, 2008
View Archived Issues
GDC-0449 shows safety and good PK profile in patients with advanced solid cancers
Read More
CuraGen reports results from phase I/II study of CR011-vcMMAE
Read More
Preclinical evaluation of novel gene therapy for the treatment of hereditary inclusion-body myositis
Read More
JNK inhibition shows benefit in experimental endometriosis
Read More
Novartis presents update on pipeline of novel vaccine candidates
Read More
First phase I clinical results for JM-1232 reported
Read More
TorreyPines initiates phase I clinical trial for oral prodrug of tezampanel
Read More
Positive opinion issued to broaden use of Erbitux, including first-line colorectal cancer
Read More
Indevus presents update on NDA for Nebido
Read More
Achillion nominates ACH-1625 as first clinical candidate in HCV protease program
Read More
Nuvelo initiates enrollment in phase Ib trial of bolus plus infusion dosing of NU-172
Read More
Nine European countries grant national marketing authorizations to SpePharm's Loramyc
Read More
Transcept to submit NDA to FDA for Intermezzo in the third quarter of 2008
Read More
Medicago reports positive results from preclinical study in ferrets of H5N1 VLP vaccine
Read More
Ipsen to acquire Tercica
Read More
FDA approves Angioblast's IND application to initiate phase II trial of allogeneic stem cells
Read More
Intercytex completes enrollment in phase III trial of Cyzact in venous leg ulcers
Read More
Arana successfully engineers second candidate antibody under collaboration with CSL
Read More
Merck Serono and ZymoGenetics initiate phase II/III trial of atacicept in SLE
Read More
Epix identifies three lead candidates in third G-protein-coupled receptor discovery program
Read More
CHMP recommends refusing Takeda's MAA for ramelteon
Read More
PharmaGap's PhG-alpha-1 reduces tumor size, increases survival in colon cancer models
Read More
Recent Devgen patent discloses novel agents for glaucoma
Read More
Novel antiinflammatory agents disclosed in recent patent literature
Read More
Recent Roche patent reports new therapeutic agents for urological disorders
Read More